Current Alzheimer Research
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 6
Author(s): Othman Ghribi*
Affiliation:
- School of Medicine and Health Sciences Room University of North Dakota Grand Forks, ND,United States
Export Options
About this article
Cite this article as:
Ghribi Othman*, Meet Our Editorial Board Member, Current Alzheimer Research 2017; 14 (6) . https://dx.doi.org/10.2174/156720501406170509185239
DOI https://dx.doi.org/10.2174/156720501406170509185239 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resisting the Sun with Vitamin D
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) MiR-125b-5p Inhibitor Might Protect Against Sevoflurane-induced Cognitive Impairments by Targeting LIMK1
Current Neurovascular Research Investigational Positive Inotropic Agents for Acute Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Current Respiratory Medicine Reviews Familial Alzheimers Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-β Protein Precursor Generated by β-Secretase Cleavage
Current Alzheimer Research Editorial: Seeking Answers to Questions in Adolescent Psychiatry
Adolescent Psychiatry Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) Catching the Therapeutic Window of Opportunity in Early Crohn`s Disease
Current Drug Targets GSK-3 Inhibitors: Discoveries and Developments
Current Medicinal Chemistry Treating Schizophrenia: Novel Targets for the Cholinergic System
CNS & Neurological Disorders - Drug Targets Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease
Current Medicinal Chemistry Sigma-1 Receptor Chaperones and Diseases
Central Nervous System Agents in Medicinal Chemistry Insight of Womens Sexual Function and Intimate Relationships AfterTermination of Pregnancy: A Review on Recent Findings and FuturePerspectives
Current Women`s Health Reviews Discovery of Novel Lead in the Group of N-substituted Piperazine Ether Derivatives with Potential Histamine H<sub>3</sub> Receptor Activity
Medicinal Chemistry Herbals and Natural Dietary Supplements in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued) Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder
Current Psychopharmacology Synthesis and Biological Activity of Hydrazones and Derivatives: A Review
Mini-Reviews in Medicinal Chemistry The Effect of Cannabis sativa L. (Hemp Seed) on Hematological Parameters in Guinea Pigs
Cardiovascular & Hematological Disorders-Drug Targets Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human Studies
Current Pharmaceutical Design